MediView XR, Inc.

Carle Illinois College of Medicine became the first in the world to use MediView XR's FDA-cleared hologram technology for patient treatment.

Discusses the use of AR for real-time image guidance in cryoneurolysis, highlighting the potential for improved navigation and outcomes in interventional radiology.

A review of AR's potential in enhancing surgical navigation for percutaneous tumor ablation, focusing on advanced needle guidance systems.

A review of current AR/VR applications in interventional radiology, with a focus on clinical impact, limitations, and future directions, including the first clinical use of XR90.

Highlights the University of Findlay's integration of MediView's MediScout technology into its Sonography Program, providing students with hands-on AR-based learning.

Carle Illinois College of Medicine is the first in the world to use MediView XR's FDA-cleared hologram technology for patient treatment.

MediView XR, Inc. announced the closing of a $9.9MM round of SAFE financing to support technology development, commercialization, and regulatory submissions.

Forbes article covering MediView XR's $9.9M funding round for its AR surgical navigation platform, enabling intraoperative 3D 'x-ray' holographic visualization.

Wired article discussing the entry of mixed reality displays into the operating room, featuring MediView's HoloLens-based technology for surgical planning and real-time guidance.

MediView AR won first place at the AAMI Exchange Xcelerator pitch competition, earning $10,000 for its 'X-ray vision' technology that superimposes 3D holograms of patient anatomy in real time for improved cancer treatment.

A study published in the Journal of Medical Imaging evaluates MediView's AR platform for minimally invasive percutaneous procedures, highlighting its potential to overcome the limitations of 2D imaging.

This article discusses the integration of AR with ultrasound equipment, marking a new generation of imaging designed with an ergonomic focus.

MediView took top honors in the Medical Capital Innovation Competition, highlighting its leadership in medical AR innovation.

Explores the use of AR to improve preoperative evaluation of disease burden in ovarian cancer.

Announces the world's first 5-patient in-human evaluation of AR-guided tumor ablation completed at the Cleveland Clinic.

Reports the world's first-in-human augmented reality tumor ablation completed at the Cleveland Clinic using MediView's technology.

Dr. Alexander Misono joins MediView's Clinical Advisory Board, bringing expertise in interventional radiology.

Dr. Francois Cornelis joins the Clinical Advisory Board, contributing his experience from Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine.

Dr. Jordan Tasse, Director of Interventional Oncology at Rush University Medical Center, joins the Clinical Advisory Board.

Study results published in the Journal of Medical Imaging demonstrate the high accuracy of MediView's XR90 AR-based surgical visualization and navigation system.

Carle Illinois College of Medicine partners with MediView to integrate AR-based hologram systems into education, innovation, and clinical programs.

Karley Yoder, General Manager & Chief Digital Officer for GE Healthcare's global ultrasound business, joins MediView's Board of Directors.

MediView receives FDA 510(k) clearance for its XR90 AR-based surgical visualization and navigation platform, intended for minimally invasive ultrasound and CT guided needle-based procedures.

MediView secures $15M in strategic funding from Mayo Clinic, Cleveland Clinic, GE HealthCare, JobsOhio Capital Growth Fund, and others.

GE HealthCare and MediView announce the first installation and clinical use of the OmnifyXR Interventional Suite at North Star Vascular and Interventional in Minneapolis, Minnesota.

First inpatient utilization of XR90 AR-based surgical visualization and navigation system since FDA 510(k) clearance, performed at NewYork-Presbyterian Hospital / Weill Cornell Medicine.

MediView participated in the SCSP AI Expo in Washington D.C., June 2-4, 2025.

MediView attended the AR/VR Policy Conference in Washington D.C., September 8, 2025.

MediView was present at the Western Angiographic & Interventional Society (WAIS) event in Colorado Springs, September 20-24, 2025.